1. Home
  2. NUKK vs QNCX Comparison

NUKK vs QNCX Comparison

Compare NUKK & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NUKK
  • QNCX
  • Stock Information
  • Founded
  • NUKK 2013
  • QNCX 2012
  • Country
  • NUKK United States
  • QNCX United States
  • Employees
  • NUKK N/A
  • QNCX N/A
  • Industry
  • NUKK Blank Checks
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NUKK Finance
  • QNCX Health Care
  • Exchange
  • NUKK Nasdaq
  • QNCX Nasdaq
  • Market Cap
  • NUKK 52.1M
  • QNCX 47.7M
  • IPO Year
  • NUKK N/A
  • QNCX 2019
  • Fundamental
  • Price
  • NUKK $8.05
  • QNCX $1.93
  • Analyst Decision
  • NUKK
  • QNCX Strong Buy
  • Analyst Count
  • NUKK 0
  • QNCX 5
  • Target Price
  • NUKK N/A
  • QNCX $8.00
  • AVG Volume (30 Days)
  • NUKK 237.7K
  • QNCX 267.4K
  • Earning Date
  • NUKK 09-10-2025
  • QNCX 08-12-2025
  • Dividend Yield
  • NUKK N/A
  • QNCX N/A
  • EPS Growth
  • NUKK N/A
  • QNCX N/A
  • EPS
  • NUKK N/A
  • QNCX N/A
  • Revenue
  • NUKK N/A
  • QNCX N/A
  • Revenue This Year
  • NUKK N/A
  • QNCX N/A
  • Revenue Next Year
  • NUKK N/A
  • QNCX N/A
  • P/E Ratio
  • NUKK N/A
  • QNCX N/A
  • Revenue Growth
  • NUKK N/A
  • QNCX N/A
  • 52 Week Low
  • NUKK $1.30
  • QNCX $0.51
  • 52 Week High
  • NUKK $78.32
  • QNCX $2.45
  • Technical
  • Relative Strength Index (RSI)
  • NUKK 33.66
  • QNCX 64.07
  • Support Level
  • NUKK $7.80
  • QNCX $1.65
  • Resistance Level
  • NUKK $8.43
  • QNCX $1.83
  • Average True Range (ATR)
  • NUKK 0.75
  • QNCX 0.15
  • MACD
  • NUKK -0.06
  • QNCX 0.00
  • Stochastic Oscillator
  • NUKK 16.41
  • QNCX 54.39

About NUKK Nukkleus Inc.

Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: